ImportRefusal LogoImportRefusal

Tallin pharmaceutical plant

⚠️ Moderate Risk

FEI: 3010375428 • Tallinn, Harjumaa • ESTONIA

FEI

FEI Number

3010375428

📍

Location

Tallinn, Harjumaa

🇪🇪

Country

ESTONIA
🏢

Address

Olevimaegi 23, , Tallinn, Harjumaa, Estonia

Moderate Risk

FDA Import Risk Assessment

25.8
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

4
Total Refusals
2
Unique Violations
11/25/2013
Latest Refusal
11/25/2013
Earliest Refusal

Score Breakdown

Violation Severity
35.0×40%
Refusal Volume
25.9×30%
Recency
0.0×20%
Frequency
40.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

3242×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

4712×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

Refusal History

DateProductViolationsDivision
11/25/2013
53LC06MOISTURIZING (SKIN CARE PREPARATIONS)
471CSTIC LBLG
New York District Office (NYK-DO)
11/25/2013
53LC06MOISTURIZING (SKIN CARE PREPARATIONS)
471CSTIC LBLG
New York District Office (NYK-DO)
11/25/2013
54YCL99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
324NO ENGLISH
New York District Office (NYK-DO)
11/25/2013
54YCB99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
324NO ENGLISH
New York District Office (NYK-DO)

Frequently Asked Questions

What is Tallin pharmaceutical plant's FDA import refusal history?

Tallin pharmaceutical plant (FEI: 3010375428) has 4 FDA import refusal record(s) in our database, spanning from 11/25/2013 to 11/25/2013.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Tallin pharmaceutical plant's FEI number is 3010375428.

What types of violations has Tallin pharmaceutical plant received?

Tallin pharmaceutical plant has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Tallin pharmaceutical plant come from?

All FDA import refusal data for Tallin pharmaceutical plant is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.